Kuaishou has acquired AcFun, which was reported earlier this year to have wound down but had in fact experienced a major server crash.

The smartphone manufacturer, which filed for a $10bn initial public offering in May, is planning to raise up to 30% of the amount in mainland China and the remainder in Hong Kong.

Pharmstandard and Access Industries-backed Neon Therapeutics has filed for a $115m initial public offering that will support a range of ongoing clinical trials.

Salesforce and WPP-backed Domo, which emerged from stealth in 2015 with a $2bn valuation, has filed to go public in an attempt to secure capital and avoid having to reduce its business.

Neuronetics has filed for an $86.3m initial public offering on Nasdaq that will offer exits to corporates Pfizer, General Electric and Ascension.

The company will sell up to approximately 7.7 million shares priced at $22.8 to $28.7, valuing the Rocket Internet-backed business at $618m to $758m.

3P Learning held a 40% stake in Learnosity after having most recently invested $13.9m in 2016, but has now sold it to Battery Ventures.

The EMS-backed gene therapy developer has filed for an $86.3m offering having raised about the same amount in venture funding.

BridgeBio Pharma retains a majority stake in spinoff Eidos, which has raised $91m in funding in just over a year.